Allianz Asset Management
ASMB icon

Allianz Asset Management’s Assembly Biosciences ASMB Stock Holding History

Allianz Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,599
Closed -$315K – 1845
2020
Q3 		$315K Sell
1,599
-1,180
-42% -$297K ﹤0.01% 1703
2020
Q2 		$778K Buy
2,779
+454
+20% +$106K ﹤0.01% 1898
2020
Q1 		$414K Sell
2,325
-2,815
-55% -$603K ﹤0.01% 2121
2019
Q4 		$1.26M Buy
+5,140
New +$947K ﹤0.01% 2087
2019
Q2 		– Sell
-3,966
Closed -$937K – 2676
2019
Q1 		$937K Sell
3,966
-18
-0.5% -$4.56K ﹤0.01% 2125
2018
Q4 		$1.08M Sell
3,984
-22
-0.5% -$6.36K ﹤0.01% 1999
2018
Q3 		$1.78M Buy
4,006
+352
+10% +$165K ﹤0.01% 1981
2018
Q2 		$1.72M Buy
3,654
+42
+1% +$22.2K ﹤0.01% 2006
2018
Q1 		$2.13M Buy
+3,612
New +$2.24M ﹤0.01% 1893

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Allianz Asset Management's ASMB Position: Q4 2020 in Review

Allianz Asset Management sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 1,599 shares — an estimated $315K sold.

Allianz Asset Management first reported a position in ASMB in Q1 2018 and held it in 9 quarters. The position peaked at $2.13M in Q1 2018. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Allianz Asset Management reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Allianz Asset Management sold 1,599 Assembly Biosciences shares in Q4 2020, an estimated $315K.
  • Allianz Asset Management first reported a position in Assembly Biosciences in Q1 2018 and held it in 9 quarters.
  • Allianz Asset Management's Assembly Biosciences position peaked at $2.13M in Q1 2018.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Allianz Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.